MELISSA SHEPPARD: Open Payments
NPI 1548023120 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 59 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,513
Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $202 |
| PFIZER INC. | 7 | $154 |
| SOBI, INC | 4 | $123 |
| ABBVIE INC. | 4 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Incyte Corporation | 3 | $72 |
| SpringWorks Therapeutics, Inc. | 3 | $70 |
| Adaptive Biotechnologies Corporation | 2 | $51 |
| GENZYME CORPORATION | 1 | $48 |
Products named: Vonjo, EPKINLY, RYBREVANT, Nubeqa, PADCEV, JAKAFI, KISQALI, clonoSEQ.
Industry payments across CO — which companies pay providers there.
